InvestingDaily.com

Account Information

  • My Account

    Manage all your subscriptions, update your address, email preferences and change your password.

  • Help Center

    Get answers to common service questions, ask the analyst or contact our customer service department.

  • My Stock Talk Profile

    Update your stock talk name and/or picture.



Close

Innogration Never Sleeps

By Jim Pearce on October 19, 2015

Long time readers of Smart Tech Investor know that at the heart of our thesis for identifying winners and losers in the tech space is our notion of “innogration”, which describes the synergistic combination of innovation and integration that produces superior products. Companies that do it well are handsomely rewarded, while the ones that don’t will pay a very steep price – or possibly disappear altogether.

The biotech sector is nothing if not innovative, and in this issue’s In Focus article Dr. Joe Duarte submits a hypothesis for why the biotech sector may be primed for a rally instead of the correction so many investors fear. He also had a new buy recommendation for this Medical Profits portfolio that will report quarterly earnings next week, so you may want to take a hard look at it before the news hits the street.

And speaking of integration, in our Sector Spotlight piece Rob DeFrancesco takes a look at M&A activity in the semiconductor industry since consolidation is the quickest way to achieve scale in an increasingly competitive business with shrinking margins.

Rob also reviews Qualys in our Portfolio Update. Qualys was added to our Next Wave portfolio in July before the August correction so its price is about 10% below what we paid for it, but Rob believes it is still a good long term buy.

Stock Talk — Post a comment Comment Guidelines

Our Stock Talk section is reserved for productive dialogue pertaining to the content and portfolio recommendations of this service. We reserve the right to remove any comments we feel do not benefit other readers. If you have a general investment comment not related to this article, please post to our Stock Talk page. If you have a personal question about your subscription or need technical help, please contact our customer service team. And if you have any success stories to share with our analysts, they’re always happy to hear them. Note that we may use your kind words in our promotional materials. Thank you.

You must be logged in to post to Stock Talk OR create an account.

Create a new Investing Daily account

  • - OR -

* Investing Daily will use any information you provide in a manner consistent with our Privacy Policy. Your email address is used for account verification and will remain private.